Related Experiment Video
Updated: Jun 16, 2026
Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
Published on: July 28, 2023
Adverse reactions in estimation of MMR vaccination validation in Bosnian population
Slobodan Trninic1, Adnan Bajraktarevic
1Health center "Sarajevo", Sarajevo, Bosnia and Herzegovina.
Introduction:
The combined MMR vaccine was introduced to induce immunity less painfully than three separate injections at the same time, and sooner and more efficiently than three injections given on different dates. MMR will protect most kids from contacting measles, mumps, or rubella throughout their lives.
Methods And Materials:
The vaccination status of all children was verified by reviews of their vaccination records. The outcome variables obtained from the public files of the Federal Health Public Institution Bosnia and Herzegovina between 1991 and 2007 were related to the receipt of MMR vaccine.
Results:
Adverse reactions, rarely serious, may occur from each component of the MMR vaccine. 3% of Bosnian children develop fever, malaise and a rash until three weeks after the first vaccination; only 1% develop temporary joint pain. When examining selective MMR non receipts, the family-level factors that have been traditionally associated with failure to immunize were no longer important.
Discussion:
Measles, mumps and rubella continues to be a leading cause of childhood morbidity and mortality in developing countries and an outbreak threat in the majority of countries.
Conclusion:
The most effective way of preventing measles is the measles-mumps-rubella (MMR) vaccine and it also provides protection against two other potentially fatal childhood conditions--mumps and rubella. Vaccination is very effective in preventing and reducing the impact of serious illness. Very few children are unable to have the MMR vaccine for medical reasons.
Insights
The measles-mumps-rubella (MMR) vaccine is highly effective in preventing serious childhood illnesses and outbreaks. While rare side effects like fever or rash can occur, the vaccine
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- The measles-mumps-rubella (MMR) vaccine was developed for less painful and more efficient immunization compared to separate injections.
- MMR vaccination protects children from measles, mumps, and rubella throughout their lives.
Purpose of the Study:
- To evaluate the effectiveness and outcomes of the combined measles-mumps-rubella (MMR) vaccine.
- To analyze vaccination status and adverse reactions in children.
Main Methods:
- Vaccination records of children were reviewed to determine MMR vaccine receipt.
- Outcome variables were collected from public health records in Bosnia and Herzegovina (1991-2007).
Main Results:
- Adverse reactions to the MMR vaccine are rarely serious; 3% experienced fever, malaise, and rash, while 1% had temporary joint pain.
- Family-level factors traditionally linked to immunization failure were not significant in cases of selective MMR non-receipt.
Conclusions:
- The measles-mumps-rubella (MMR) vaccine is the most effective method for preventing measles, mumps, and rubella, significantly reducing childhood morbidity and mortality.
- Vaccination is crucial for preventing and mitigating the impact of these serious childhood diseases, with very few medical contraindications.
